CS logo
small CS logo
Krankenhaus Martha-Maria Halle-Doelau gGmbH

Halle, Germany
Krankenhaus in Halle (Saale), Sachsen-Anhalt

About Krankenhaus Martha-Maria Halle-Doelau gGmbH


"Erkrankungen vorbeugen und gesund werden mit Blick ins Grüne: Dafür steht das Krankenhaus Martha-Maria Halle-Dölau. Ob Sie geplant oder als Notfallpatient kommen, wir sind für Sie da. Ihre Sorgen und Unsicherheiten in Zeiten der Krankheit verstehen wir gut. Darum sehen wir es als unsere Aufgabe an, Ihren Weg ebenso fachkundig wie fürsorglich zu begleiten. Wir bieten Spitzenmedizin und Nächstenliebe an einem Ort. Dazu gehören auch Beratungen vor sowie die Nachsorge nach Operationen und anderen Therapien. Das Krankenhaus Martha-Maria Halle-Dölau ist als Einrichtung im Diakoniewerk Martha-Maria auch ein Akademisches Lehrkrankenhaus der Martin-Luther-Universität Halle-Wittenberg."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
German High-Grade Non-Hodgkin's Lymphoma Study Group
4
Boehringer Ingelheim
3
Hoffmann-La Roche
3
AIO-Studien-gGmbH
2
Janssen Research & Development, LLC
2
Shire
2
Charite University, Berlin, Germany
1
Gilead Sciences
1
Human Genome Sciences Inc.
1
Leipzig Heart Institute GmbH
1
University Hospital, Essen
1
Total Rows: 12

Clinical Trials at Krankenhaus Martha-Maria Halle-Doelau gGmbH


During the past decade, Krankenhaus Martha-Maria Halle-Doelau gGmbH conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years44111111113311110000220011111100Started TrialsCompleted Trails201520162017201820192020202120220246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
2005-11-01
2018-02-01
Completed
700
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
2007-01-01
2011-02-01
Completed
111
LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer
2008-12-03
2017-11-13
Completed
1,314
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
2011-04-06
2015-10-09
Completed
265
A Study To Monitor Long-Term Treatment With PF-00547659
2011-07-01
2016-07-27
Completed
268

Rows per page:

1–22 of 22

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Krankenhaus Martha-Maria Halle-Doelau gGmbH" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "AIO-Studien-gGmbH" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Krankenhaus Martha-Maria Halle-Doelau gGmbH" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "Johannes Gutenberg University Mainz" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGerman High-GradeNon-Hodgkin'sLymphoma StudyGroup: 4German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 4Boehringer Ingelheim: 3Boehringer Ingelheim: 3Hoffmann-La Roche: 3Hoffmann-La Roche: 3AIO-Studien-gGmbH: 2AIO-Studien-gGmbH: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Shire: 2Shire: 2Charite University,Berlin, Germany: 1Charite University,Berlin, Germany: 1Gilead Sciences: 1Gilead Sciences: 1Human Genome Sciences Inc.: 1Human Genome Sciences Inc.: 1Leipzig Heart Institute GmbH: 1Leipzig Heart Institute GmbH: 1

Created with Highcharts 11.1.0Top CollaboratorsAstraZeneca: 1AstraZeneca: 1Celgene: 1Celgene: 1Heart Center Leipzig -University Hospital: 1Heart Center Leipzig -University Hospital: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1Johannes GutenbergUniversity Mainz: 1Johannes GutenbergUniversity Mainz: 1Merck Sharp & Dohme LLC: 1Merck Sharp & Dohme LLC: 1NeuroCure ClinicalResearch Center,Charite, Berlin: 1NeuroCure ClinicalResearch Center,Charite, Berlin: 1

Clinical Trials Conditions at Krankenhaus Martha-Maria Halle-Doelau gGmbH


According to Clinical.Site data, the most researched conditions in "Krankenhaus Martha-Maria Halle-Doelau gGmbH" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Lymphoma" (4 trials), "Crohn's Disease" (2 trials), "Non Small Cell Lung Cancer" (2 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Krankenhaus Martha-Maria Halle-Doelau gGmbH" in a lesser frequency.

Clinical Trials Intervention Types at Krankenhaus Martha-Maria Halle-Doelau gGmbH


Most popular intervention types in "Krankenhaus Martha-Maria Halle-Doelau gGmbH" are "Drug" (19 trials), "Biological" (5 trials), "Radiation" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (6 trials), "cyclophosphamide" (4 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials) and "radiation therapy" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Krankenhaus Martha-Maria Halle-Doelau gGmbH


The vast majority of trials in "Krankenhaus Martha-Maria Halle-Doelau gGmbH" are 22 trials for "All" genders.

Clinical Trials Status at Krankenhaus Martha-Maria Halle-Doelau gGmbH


Currently, there are NaN active trials in "Krankenhaus Martha-Maria Halle-Doelau gGmbH". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Krankenhaus Martha-Maria Halle-Doelau gGmbH, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Krankenhaus Martha-Maria Halle-Doelau gGmbH, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 8Phase 2: 8Phase 3: 8Phase 3: 8Not Applicable: 2Not Applicable: 2Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12Active, not recruiting: 4Active, not recruiting: 4Recruiting: 4Recruiting: 4Terminated: 2Terminated: 2

Departments of Krankenhaus Martha-Maria Halle-Doelau gGmbH


Krankenhaus Martha-Maria Halle-Doelau gGmbH has several departments that took part in Clinical trials: "Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin II" - 8 trials, "Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie" - 4 trials, "Krankenhaus Martha-Maria Halle-Doelau gGmbH; Klinik fuer Innere Medizin I" - 3 trials, "Krankenhaus Martha-Maria Halle-Doelau, Klinik fuer Neurologie" - 2 trials